LIPOPHARMA
Lipopharma is a pioneering clinical-stage biopharmaceutical company that focuses its activities on the discovery, rational design and clinical development of a new generation of medicines that act through the selective regulation of membrane lipids, a novel therapeutic strategy known as “Membrane Lipid Therapy” (MLT). Lipopharma arose as an academic spin-off, founded to turn new scientific breakthroughs and discoveries made by scientists at the Institute of Health Science Research (IUNICS - part of the University of the Balearic Islands in Mallorca, Spain) into a new class of innovative lipid regulator therapeutic agents that they believe have dramatic game-changing potential in the treatment of life-threatening conditions like cancer, CNS, inflammatory or metabolic diseases
LIPOPHARMA
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2007-01-01
Address:
Palma De Mallorca, Islas Baleares, Spain
Country:
Spain
Website Url:
http://www.lipopharma.com
Total Employee:
1+
Status:
Closed
Contact:
34 97 143 98 86
Email Addresses:
[email protected]
Total Funding:
6.15 M EUR
Technology used in webpage:
Internet Names For Business
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Grant - Lipopharma
Official Site Inspections
http://www.lipopharma.com
- Host name: 82.223.29.228
- IP address: 82.223.29.228
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Lipopharma"
Lipopharma Org Chart - The Org
Lipopharma is company that designs and develops synthetic bio-active lipids that interact with proteins involved in serious diseases. It takes less than ten minutes to set up your company page. It’s free to use - try it out today. Explore …See details»
Lipopharma - Crunchbase Company Profile & Funding
Lipopharma is a pioneering clinical-stage biopharmaceutical company that focuses its activities on the discovery, rational design and clinical development …See details»
Lipopharma Therapeutics SL - VentureRadar
Lipopharma is focused on the discovery, rational design and initial clinical development of a new generation of medicines associated with a novel... ... Find out more about Lipopharma …See details»
Lipopharma Therapeutics S.L. - Life-Sciences-Europe.com
Oct 12, 2012 · Lipopharma is a pioneering clinical-stage biopharmaceutical company that focuses on the discovery, design and clinical development of a new generation of medicines that act …See details»
Lipopharma Therapeutics SL - Drug pipelines, Patents ... - Patsnap
Explore Lipopharma Therapeutics SL with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Nervous System Diseases, Technology Platform:Small …See details»
Lipopharma - Funding, Financials, Valuation & Investors
Lipopharma is company that designs and develops synthetic bio-active lipids that interact with proteins involved in serious diseases.See details»
Lipopharma - Company Profile & Staff Directory - ContactOut
Lipopharma is a pioneering clinical-stage biopharmaceutical company that focuses its activities on the discovery, rational design and clinical development of a new generation of medicines that …See details»
Lipopharma - Crunchbase
Lipopharma is company that designs and develops synthetic bio-active lipids that interact with proteins involved in serious diseases.See details»
Lipopharma, Inc. Company Profile | Acton, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Lipopharma, Inc. of Acton, MA. Get the latest business insights from Dun & Bradstreet.See details»
Lipopharma Therapeutics S.L. - BioCentury Company Profiles - BCIQ
Lipopharma Therapeutics S.L. - BioCentury Company Profiles for the biopharma industrySee details»
EU/3/11/916 - orphan designation for treatment of glioma
On 27 October 2011, orphan designation (EU/3/11/916) was granted by the European Commission to Lipopharma Therapeutics SL, Spain, for 2-hydroxyoleic acid for the treatment …See details»
LP226A1 for the treatment of Alzheimer's disease
LP226A1 (OHDHA) enriches brain membranes in PE, specially those carrying DHA and other PUFAs. These lipid changes influence the structure of the cell membrane, leading to the …See details»
LMBRI and Lipopharma Lead Collaboration to Promote New …
Jun 15, 2010 · Under terms of the agreement, Lipopharma is appointing LMBRI to commercialize its world-wide rights of its platform technology and products for licensing and marketing. The …See details»
Research programme: cancer diagnostics and therapeutics
Laminar Pharmaceuticals (formerly Lipopharma Therapeutics) is developing cancer diagnostic and therapeutic agents using their proprietary Membrane Lipid-TherapySee details»
Vicenç Tur - Crunchbase Person Profile
Vicenç Tur is Co-founder, CEO & President of the Board of Lipopharma Therapeutics (renamed to Laminar Pharmaceutical in 2019), an innovative biotechnology project proposing a new …See details»
S&D Lipopharma
S&D Lipopharma is a consulting, contract research and custom synthesis company intended to serve the chemists, biologists, immunologists and other interdisciplinary communities.See details»
Minerval - biodeutschland.org
MLT drugs are designed to influence and regulate lipid organization in cell membranes based on structure–function principles, inducing a concomitant modulation of membrane protein …See details»
Membrane Lipid Composition: Effect on Membrane and Organelle …
May 1, 2019 · Here, we review current knowledge on membrane lipid composition in the plasma membrane and endomembrane compartments, emphasizing its role in sustaining organelle …See details»
Recent advances with liposomes as drug carriers for treatment of ...
Jul 19, 2021 · In this review, we summarized the development of liposome-based drug delivery system with enhanced BBB penetration for efficient brain drug delivery. We focused on the …See details»